D. Pim et al., ALTERNATIVELY SPLICED HPV-18 E6-ASTERISK PROTEIN INHIBITS E6 MEDIATEDDEGRADATION OF P53 AND SUPPRESSES TRANSFORMED-CELL GROWTH, Oncogene, 15(3), 1997, pp. 257-264
The E6 proteins originating from the tumour-associated Human Papilloma
virus (HPV) types 16 and 18 have been shown to bind to and target the
tumour suppressor protein, p53, for ubiquitin-mediated degradation. Ho
wever, in cell lines derived from cervical neoplasias, the predominant
early region transcripts are spliced and encode truncated forms of E6
, termed E6. We report here that HPV-18 E6* protein will interact bot
h with the full-length E6 proteins from HPV-16 and HPV-18 and also wit
h E6-AP, and subsequently blocks the association of full length E6 pro
tein with p53. We also show that, as a result of this block, E6 can i
nhibit E6-mediated degradation of p53 both in vitro and in vivo. The b
iological consequences of this are increased transcriptional activity
on p53-responsive promoters and an inhibition of cell growth in cells
transfected with E6. This is the first report of a potential biologic
al function for this polypeptide and may represent a means by which HP
V is able to modulate the activity of the full-length E6 protein with
respect to p53 during viral infection.